Bengt Johansson

Dr. Bengt Johansson


Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2005 in Circulation
Verified
Journal Article
Closed access
PDF file
GDGerhard-Paul Diller
Gerhard-Paul Diller
KDKonstantinos Dimopoulos
Konstantinos Dimopoulos
DODarlington Okonko
Darlington Okonko
WLWei Li
Wei Li
SBSonya V. Babu-Narayan
Sonya V. Babu-Narayan
MGMichael A. Gatzoulis
Michael A. Gatzoulis
Background— Although some patients with adult congenital heart disease (ACHD) report limitations in exercise capacity, we hypothesized that depressed exercise capacity may be more widespread than superficially evident during clinical consultation and could be a means of assessing risk. Methods and Results— Cardiopulmonary exercise testing was performed in 335 consecutive ACHD patients (age, 33±13 years), 40 non–congenital heart failure patients (age, 58±15 years), and 11 young (age, 29±5 years) and 12 older (age, 59±9 years) healthy subjects. Peak oxygen consumption (peak V̇ o 2 ) was reduced in ACHD patients compared with healthy subjects of similar age (21.7±8.5 versus 45.1±8.6; P <0.001). No significant difference in peak V̇ o 2 was found between ACHD and heart failure patients of corresponding NYHA class ( P =NS for each NYHA class). Within ACHD subgroups, peak V̇ o 2 gradually declined from aortic coarctation (28.7±10.4) to Eisenmenger (11.5±3.6) patients ( P <0.001). Multivariable correlates of peak V̇ o 2 were peak heart rate ( r =0.33), forced expiratory volume ( r =0.33), pulmonary hypertension ( r =−0.26), gender ( r =−0.23), and body mass index ( r =−0.19). After a median follow-up of 10 months, 62 patients (18.5%) were hospitalized or had died. On multivariable Cox analysis, peak V̇ o 2 predicted hospitalization or death (hazard ratio, 0.937; P =0.01) and was related to the frequency and duration of hospitalization ( P =0.01 for each). Conclusions— Exercise capacity is depressed in ACHD patients (even in allegedly asymptomatic patients) on a par with chronic heart failure subjects. Lack of heart rate response to exercise, pulmonary arterial hypertension, and impaired pulmonary function are important correlates of exercise capacity, as is underlying cardiac anatomy. Poor exercise capacity identifies ACHD patients at risk for hospitalization or death.

25 August 2015 in Circulation
Verified
Journal Article
Closed access
PDF file
NVNiels Vejlstrup
Niels Vejlstrup
KSKeld Sørensen
Keld Sørensen
EMEva Mattsson
Eva Mattsson
UTUlf Thilén
Ulf Thilén
PKPer Kvidal
Per Kvidal
PEPeter Eriksson
Peter Eriksson
Background—: The atrial switch operation, the Mustard or Senning operation, for the transposition of the great arteries (TGA) was introduced in the late 1950s and was the preferred surgery for TGA until the early 1990s. The Mustard and Senning operation involves extensive surgery in the atria and leaves the right ventricle as the systemic ventricle. The Mustard and Senning cohort is now well into adulthood and we begin to see the long-term outcome. Methods and Results—: All the 6 surgical centers that performed Mustard and Senning operations in Sweden and Denmark identified all operated TGA patients. Information about death was obtained in late 2007 and early 2008 from the Danish and Swedish Centralised Civil Register by using the patients’ unique national Civil Registration Numbers. Four hundred sixty-eight patients undergoing the atrial switch operation were identified. Perioperative 30-day mortality was 20%, and 60% were alive after 30 years of follow-up. Perioperative mortality was significantly increased by the presence of a ventricular septal defect, left ventricular outflow obstruction, surgery early in the Mustard and Senning era. However, only pacemaker implantation is predictive of long-term outcome (hazard ratio, 1.90; 95% confidence interval, 1.05–3.46, P =0.04), once the TGA patient has survived the perioperative period. The risk of reoperation was correlated to the presence of associated defects and where the first Mustard/Senning operation was performed. Conclusions—: The long-term survival of patients with Mustard and Senning correction for TGA appears to be primarily determined by factors in the right ventricle and tricuspid valve and not the timing of or the type of surgery in childhood. Cardiac function necessitating the implantation of a pacemaker is associated with an increase in mortality.

11 April 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
HCHao Yu Chen
Hao Yu Chen
CDChristian Dina
Christian Dina
ASAeron M Small
Aeron M Small
CSChristian M Shaffer
Christian M Shaffer
RLRebecca T Levinson
Rebecca T Levinson
GTGeorge Thanassoulis
George Thanassoulis
Although highly heritable, the genetic etiology of calcific aortic stenosis (AS) remains incompletely understood. The aim of this study was to discover novel genetic contributors to AS and to integrate functional, expression, and cross-phenotype data to identify mechanisms of AS. A genome-wide meta-analysis of 11.6 million variants in 10 cohorts involving 653 867 European ancestry participants (13 765 cases) was performed. Seventeen loci were associated with AS at P ≤ 5 × 10−8, of which 15 replicated in an independent cohort of 90 828 participants (7111 cases), including CELSR2–SORT1, NLRP6, and SMC2. A genetic risk score comprised of the index variants was associated with AS [odds ratio (OR) per standard deviation, 1.31; 95% confidence interval (CI), 1.26–1.35; P = 2.7 × 10−51] and aortic valve calcium (OR per standard deviation, 1.22; 95% CI, 1.08–1.37; P = 1.4 × 10−3), after adjustment for known risk factors. A phenome-wide association study indicated multiple associations with coronary artery disease, apolipoprotein B, and triglycerides. Mendelian randomization supported a causal role for apolipoprotein B-containing lipoprotein particles in AS (OR per g/L of apolipoprotein B, 3.85; 95% CI, 2.90–5.12; P = 2.1 × 10−20) and replicated previous findings of causality for lipoprotein(a) (OR per natural logarithm, 1.20; 95% CI, 1.17–1.23; P = 4.8 × 10−73) and body mass index (OR per kg/m2, 1.07; 95% CI, 1.05–1.9; P = 1.9 × 10−12). Colocalization analyses using the GTEx database identified a role for differential expression of the genes LPA, SORT1, ACTR2, NOTCH4, IL6R, and FADS. Dyslipidemia, inflammation, calcification, and adiposity play important roles in the etiology of AS, implicating novel treatments and prevention strategies. Genetic etiology of aortic stenosis. This study meta-analyzed 13 765 AS cases vs. 640 102 controls and confirmed 15 genetic loci associated with AS. Downstream analyses implicated additional candidate genes involved in dyslipidemia, inflammation, calcification, and adiposity. The Manhattan plot shows variants with P ≥ 1 × 10−25, for improved visualization. Genetic loci in grey were previously identified, and those in gold are new discoveries. Abbreviations: AS, aortic stenosis; GWAS, genome-wide association study; LDL, low-density lipoprotein.

1 January 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
SASilke Apers
Silke Apers
AKAdrienne H. Kovacs
Adrienne H. Kovacs
KLKoen Luyckx
Koen Luyckx
LALuis Alday
Luis Alday
MBMalin Berghammer
Malin Berghammer
PMPhilip Moons
Philip Moons

18 April 2017 in European Heart Journal
Verified
Journal Article
Open access
PDF file
CHCristel M. Sørensen Hjortshøj
Cristel M. Sørensen Hjortshøj
AKAleksander Kempny
Aleksander Kempny
AJAnnette Schophuus Jensen
Annette Schophuus Jensen
KSKeld Sørensen
Keld Sørensen
ENEdit Nagy
Edit Nagy
LSLars Søndergaard
Lars Søndergaard
Eisenmenger syndrome (ES) is associated with considerable morbidity and mortality. Therapeutic strategies have changed during the 2000s in conjunction with an emphasis on specialist follow-up. The aim of this study was to determine the cause-specific mortality in ES and evaluate any relevant changes between 1977 and 2015. This is a retrospective, descriptive multicentre study. A total of 1546 patients (mean age 38.7 ± 15.4 years; 36% male) from 13 countries were included. Cause-specific mortality was examined before and after July 2006, ‘early’ and ‘late’, respectively. Over a median follow-up of 6.1 years (interquartile range 2.1–21.5 years) 558 deaths were recorded; cause-specific mortality was identified in 411 (74%) cases. Leading causes of death were heart failure (34%), infection (26%), sudden cardiac death (10%), thromboembolism (8%), haemorrhage (7%), and peri-procedural (7%). Heart failure deaths increased in the ‘late’ relative to the ‘early’ era (P = 0.032), whereas death from thromboembolic events and death in relation to cardiac and non-cardiac procedures decreased (P = 0.014, P = 0.014, P = 0.004, respectively). There was an increase in longevity in the ‘late’ vs. ‘early’ era (median survival 52.3 vs. 35.2 years, P < 0.001). The study shows that despite changes in therapy, care, and follow-up of ES in tertiary care centres, all-cause mortality including cardiac remains high. Patients from the ‘late’ era, however, die later and from chronic rather than acute cardiac causes, primarily heart failure, whereas peri-procedural and deaths due to haemoptysis have become less common. Lifelong vigilance in tertiary centres and further research for ES are clearly needed.

1 January 2009 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
BJBengt Johansson
Bengt Johansson
SBSonya V Babu-Narayan
Sonya V Babu-Narayan
PKPhilip J Kilner
Philip J Kilner
Pulmonary regurgitation is a common and clinically important residual lesion after repair of tetralogy of Fallot. Cardiovascular magnetic resonance (CMR) phase contrast velocity mapping is widely used for measurement of pulmonary regurgitant fraction. Breath-hold acquisitions, usually acquired during held expiration, are more convenient than the non-breath-hold approach, but we hypothesized that breath-holding might affect the amount of pulmonary regurgitation.